title: Optimizing MDR-TB clinical trials: insights from the first global MDR-TB Clinical Trials Landscape Meeting.
authors.affiliation: Department of Epidemiology, Boston University School of Public Health, USA; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
authors.forename: C Robert
authors.initials: CR
authors.lastname: Horsburgh
authors.affiliation: Vital Strategies, New York, New York, USA.
authors.forename: I D
authors.initials: ID
authors.lastname: Rusen
authors.affiliation: Department of Global Health and Social Medicine, Harvard Medical School, USA; Partners In Health, Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Carole D
authors.initials: CD
authors.lastname: Mitnick
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy*; D003226:Congresses as Topic
chemical_list: D000995:Antitubercular Agents